Product

Case Studies

Security

News

About

Sign In

Get Started

Product

Case Studies

Security

News

About

Sign In

Get Started

K2 Medical Research Accelerates Recruitment for 50+ Years Old Demographic with Grove AI
A leading SMO uses Grace and the Grove AI PRM™ to streamline complex recruitment processes for participants aged 50+ with memory-related conditions.

40.5%

Prescreen Visit Completion Rate

66%

Screening Qualification Rate

15,000+

Automated Personalized Interactions

K2 Medical Research Accelerates Recruitment for 50+ Years Old Demographic with Grove AI
A leading SMO uses Grace and the Grove AI PRM™ to streamline complex recruitment processes for participants aged 50+ with memory-related conditions.

40.5%

Prescreen Visit Completion Rate

66%

Screening Qualification Rate

15,000+

Automated Personalized Interactions

K2 Medical Research Accelerates Recruitment for 50+ Years Old Demographic with Grove AI
A leading SMO uses Grace and the Grove AI PRM™ to streamline complex recruitment processes for participants aged 50+ with memory-related conditions.

40.5%

Prescreen Visit Completion Rate

66%

Screening Qualification Rate

15,000+

Automated Personalized Interactions

K2 Medical Research Accelerates Recruitment for 50+ Years Old Demographic with Grove AI
A leading SMO uses Grace and the Grove AI PRM™ to streamline complex recruitment processes for participants aged 50+ with memory-related conditions.

40.5%

Prescreen Visit Completion Rate

66%

Screening Qualification Rate

15,000+

Automated Personalized Interactions

Celerion Increases Screening Pass Rate by 28% with Grove AI
A large Phase I CRO uses Grace and the Grove AI PRM™ to increase screening pass rates and drive recruitment efficiency for a kidney disease trial.

+28%

On-site Screening Pass Rate

$20,000+

Saved in 2 Days

39,000+

Participants Prescreened

Celerion Increases Screening Pass Rate by 28% with Grove AI
A large Phase I CRO uses Grace and the Grove AI PRM™ to increase screening pass rates and drive recruitment efficiency for a kidney disease trial.

+28%

On-site Screening Pass Rate

$20,000+

Saved in 2 Days

39,000+

Participants Prescreened

Celerion Increases Screening Pass Rate by 28% with Grove AI
A large Phase I CRO uses Grace and the Grove AI PRM™ to increase screening pass rates and drive recruitment efficiency for a kidney disease trial.

+28%

On-site Screening Pass Rate

$20,000+

Saved in 2 Days

39,000+

Participants Prescreened

Celerion Increases Screening Pass Rate by 28% with Grove AI
A large Phase I CRO uses Grace and the Grove AI PRM™ to increase screening pass rates and drive recruitment efficiency for a kidney disease trial.

+28%

On-site Screening Pass Rate

$20,000+

Saved in 2 Days

39,000+

Participants Prescreened

Leading Site Network Schedules 580% More Participants with Grove AI
A large, US-based site network uses Grace and the Grove AI PRM™ to prescreen and schedule tens of thousands of participant leads across 15+ sites.

+580%

Scheduled On-site Visit

+24%

Picked Up The First Call

+56%

Showed Up For On-site Visit

Leading Site Network Schedules 580% More Participants with Grove AI
A large, US-based site network uses Grace and the Grove AI PRM™ to prescreen and schedule tens of thousands of participant leads across 15+ sites.

+580%

Scheduled On-site Visit

+24%

Picked Up The First Call

+56%

Showed Up For On-site Visit

Leading Site Network Schedules 580% More Participants with Grove AI
A large, US-based site network uses Grace and the Grove AI PRM™ to prescreen and schedule tens of thousands of participant leads across 15+ sites.

+580%

Scheduled On-site Visit

+24%

Picked Up The First Call

+56%

Showed Up For On-site Visit

Leading Site Network Schedules 580% More Participants with Grove AI
A large, US-based site network uses Grace and the Grove AI PRM™ to prescreen and schedule tens of thousands of participant leads across 15+ sites.

+580%

Scheduled On-site Visit

+24%

Picked Up The First Call

+56%

Showed Up For On-site Visit

Accelerating Clinical Trials With
Participant Relationships

Get Started

San Francisco, CA 94104

United States

support@grovetrials.com

LinkedIn

Product

Case Studies

Security

News

About Us

© 2024 Grove AI Inc. All rights reserved.

Names and images on this website do not represent real individuals.

Terms of Service

Privacy Policy

Accelerating Clinical Trials With
Participant Relationships

Get Started

San Francisco, CA 94104

United States

support@grovetrials.com

LinkedIn

Product

Case Studies

Security

News

About Us

© 2024 Grove AI Inc. All rights reserved.

Names and images on this website do not represent real individuals.

Terms of Service

Privacy Policy

Accelerating Clinical Trials With
Participant Relationships

Get Started

San Francisco, CA 94104

United States

support@grovetrials.com

LinkedIn

Product

Case Studies

Security

News

About Us

© 2024 Grove AI Inc. All rights reserved.

Names and images on this website do not represent real individuals.

Terms of Service

Privacy Policy

Accelerating Clinical
Trials With Participant Relationships

Get Started

Product

Case Studies

Security

News

About Us

San Francisco, CA 94104

United States

support@grovetrials.com

LinkedIn

© 2024 Grove AI Inc. All rights reserved.

Names and images on this website do not represent real individuals.

Terms of Service

Privacy Policy